Open Advanced Search. DeepDyve requires Javascript to function. Please enable Javascript on your browser to continue. Read Article. Download PDF. Share Full Text for Free. Web of Science. Let us know here. System error. Please try again! How was the reading experience on this article? The text was blurry Page doesn't load Other:. Details Include any more information that will help us locate the issue and fix it faster for you.
Thank you for submitting a report! Submitting a report will send us an email through our customer support system. Submit report Close. Recommended Articles Loading References Serious adverse drug events reported to the Food and Drug Administration, — Liver transplantation for acute liver failure from drug induced liver injury in the United States. Causality assessment in drug-induced hepatotoxicity. Assessment of drug-induced liver injury in clinical practice.
Causality assessment versus guilt-by-association in drug hepatotoxicity. Causality assessment of adverse reactions to drugs: II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.
Mitochondrial enzyme deficiency causing exercise limitation in normal-appearing adults. Engel WK. Reversible ocular myasthenia gravis or mitochondrial myopathy from statins? Windler E. Should lipid-lowering agents be prescribed in myasthenia?
Dtsch Med Wochenschr. Reactive oxygen species mediate pyridostigmine-induced neuronal apoptosis: involvement of muscarinic and NMDA receptors. Toxicol Appl Pharmacol. Anticholinesterase toxicity and oxidative stress. Mitochondrial dysfunction in myasthenia gravis. Arq Neuropsiquiatr. Sporadic rippling muscle disease unmasked by simvastatin.
Disorder resembling Guillain-Barre syndrome on initiation of statin therapy. Drug tendon disorders. Tunis Med. Four cases of tendinopathy in patients on statin therapy. Joint Bone Spine. Am J Cardiol. Reproducible tendinitis-like symptoms related to statin therapy. J Clin Rheumatol.
Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period and review of the literature. Arthritis Rheum. Damage to mitochondria of cultured human skin fibroblasts photosensitized by fluoroquinolones.
J Photochem Photobiol B. Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol Pharmacol.
Age-dependent effects on redox status, oxidative stress, mitochondrial activity and toxicity induced by fluoroquinolones on primary cultures of rabbit tendon cells. Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment. J Rheumatol. Investigation of fluoroquinolone-induced myalgia using 31 P magnetic resonance spectroscopy and in vitro contracture tests. A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin.
Intern Med. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Amyotrophic lateral sclerosis-like conditions arising in association with cholesterol-lowering drugs: Hypothesized role for oxidative stress and mitochondrial injury.
Drug Safety. Fatal and widespread skeletal myopathy confirmed morphologically years after initiation of simvastatin therapy. Severe myopathy associated with vitamin D deficiency in western New York. Mitochondrial dysfunction in amyotrophic lateral sclerosis also affects skeletal muscle. Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Neuropathol Appl Neurobiol. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis.
Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci. Spontaneous compartment syndrome in association with simvastatin-induced myositis. Emerg Med J. Simvastatin-induced bilateral leg compartment syndrome and myonecrosis associated with hypothyroidism. Postgrad Med J. Genetic risk factors associated with lipid-lowering drug-induced myopathies.
Statin myotoxicity is associated with changes in the cardiopulmonary function. Presymptomatic neuromuscular disorders disclosed following statin treatment. McArdle's disease diagnosed following statin-induced myositis. Ann Clin Biochem. Statin-disclosed acid maltase deficiency. J Intern Med. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Rhabdomyolysis and lipid-lowering drugs. Phillips PS. How common is rhabdomyolysis in patients receiving lipid-lowering therapy? Nat Clin Pract Cardiovasc Med. Statin-associated rhabdomyolysis. Statin safety: an assessment using an administrative claims database. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.
Severe muscle disorders associated with statins: analysis of cases notified in France up to the end of February and data concerning the risk profile of cerivastatin.
Effects of fibrates on metabolism of statins in human hepatocytes. Drug Metab Dispos. Mechanistic studies on metabolic interactions between gemfibrozil and statins.
J Pharmacol Exp Ther. Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis. Tenn Med. Adverse events with concomitant amiodarone and statin therapy. Prev Cardiol. Sun D, Fernandes G. Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production. Cell Immunol. Statin-related adverse events: a meta-analysis. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
Risks associated with statin therapy: a systematic overview of randomized clinical trials. Mar , Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. Statins: beneficial or adverse for glucose metabolism. J Atheroscler Thromb. Efficacy and safety of pravastatin in the treatment of Type I or Type II diabetes mellitus and hypercholesterolemia.
Occurrences of rhabdomyolysis or myositis among statin users in a Veteran Affairs population abstract from presentation at the AHA Council on Epidemiology and Prevention meeting in March , San Francisco Circulation. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. Lennernas H, Fager G. Similarities and differences. Clin Pharmacokinet. Feedback-type inhibition of activity of 3-hydroxymethylglutaryl coenzyme a reductase by ubiquinone. Biochem Biophys Res Commun. Apr , Steinberg D. Thematic review series: the pathogenesis of atherosclerosis.
An interpretive history of the cholesterol controversy: part I. J Lipid Res. Stein E. The lower the better? Reviewing the evidence for more aggressive cholesterol reduction and goal attainment. Atheroscler Suppl. O'Keefe JH, Jr. Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials.
Myopathy and rhabdomyolysis with lovastatin taken with gemfibrozil. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.
Rhabdomyolysis after taking atorvastatin with gemfibrozil. Rhabdomyolysis associated with simvastatin-gemfibrozil therapy. Southern Medical Journal. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil [letter] American Journal of Medicine.
Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil. American Journal of Health-System Pharmacy. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole.
Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil. Severe rhabdomyolysis related to cerivastatin without gemfibrozil. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen. Br J Gen Pract. Severe rhabdomyolysis and cerivastatin-gemfibrozil combination therapy. Rhabdomyolysis associated with combined treatment of cerivastatin and gemfibrozil. Rev Clin Esp. Massive rhabdomyolysis and life threatening hyperkalaemia in a patient with the combination of cerivastatin and gemfibrozil.
Nephrol Dial Transplant. Cerivastatin and gemfibrozil-associated rhabdomyolysis. Severe rhabdomyolysis associated with cerivastatin and gemfibrozil. Med Clin Barc ; —9. Rhabdomyolysis complicated with acute renal insufficiency in a patient treated with gemfibrozil and cerivastatin.
Tomlinson B, Lan IW. Combination therapy with cerivastatin and gemfibrozil causing rhabdomyolysis: is the interaction predictable?
Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence. Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case. Tex Heart Inst J.
Protective effect of coenzyme Q10 in simvastatin and gemfibrozil induced rhabdomyolysis in rats. Indian J Exp Biol. Gouton M. Hypothyroidism, hypocholesteremic agents and rhabdomyolysis. Chrysanthopoulos C, Kounis N.
Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine. Bmj Clinical Research Ed. Reaven P, Witztum JL. Lovastatin, nicotinic acid, and rhabdomyolysis. Rhabdomyolysis associated to combined ezetimibe-statin treatment. FDA adverse event reports on statin-associated rhabdomyolysis.
Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias [see comments] American Journal of Cardiology. Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate. Simvastatin, fenofibrate, and rhabdomyolysis.
Diabetes Care. Rhabdomyolysis associated with pomegranate juice consumption. Myopathy associated with atorvastatin-ezetimibe combination therapy.
Molden E, Andersson KS. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients. Myopathy and rhabdomyolysis with lovastatin taken with gemfibrozil [letter; comment] Jama. Interactions between statins and macrolide antibiotics. Tidsskr Nor Laegeforen. Rhabdomyolysis associated with lovastatin and erythromycin use.
West J Med. Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin. Annals of Pharmacotherapy. Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction. Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tcm MDP scintigraphy. Clin Nucl Med. Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin. HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions.
Intern Med J. Gilad R, Lampl Y. Rhabdomyolysis induced by simvastatin and ketoconazole treatment. Clinical Neuropharmacology. Rhabdomyolysis from cytochrome p interaction of ketoconazole and simvastatin in prostate cancer.
J Urol. A lesson for everyone in drug-drug interactions. Int J Cardiol. Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole. Itraconazole-induced rhabdomyolysis and acute renal failure in a heart transplant recipient treated with simvastatin and cyclosporine.
Horn M. Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals. Arch Dermatol. Simvastatin-fluconazole causing rhabdomyolysis. Rhabdomyolysis after simvastatin therapy in an HIV-infected patient with chronic renal failure. Transplant Proc. Rhabdomyolysis in a patient treated with lovastatin and cyclosporine.
An Med Interna. Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P enzyme system activity. Cerivastatin-induced rhabdomyolysis in a renal transplant on cyclosporin. Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient.
Med Sci Monit. Peces R, Pobes A. Rhabdomyolysis associated with concurrent use of simvastatin and diltiazem. Rhabdomyolysis in cardiac transplant recipient due to verapamil interaction with simvastatin and cyclosporin treatment. Case report: rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatin.
J Clin Pharmacol. Rhabdomyolysis due to interaction of simvastatin with mibefradil. Risperidone and severe cerivastatin-induced rhabdomyolysis. Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin.
J Psychopharmacol. Rhabdomyolysis caused by the association of simvastatin and risperidone. Med Clin Barc ; Hyperventilation associated with quetiapine.
Drug metabolism and atypical antipsychotics. Eur Neuropsychopharmacol. Rhabdomyolysis in neuroleptics: are we talking of neuroleptic malignant syndrome? Aten Primaria. Olanzapine-induced acute rhabdomyolysis-a case report. Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine. Rhabdomyolysis: an evaluation of hospitalized patients. Medicine Baltimore ; 84 — Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment.
Rhabdomyolysis associated with respiratory infection in chronic psychiatric patients during neuroleptic treatment. Minerva Anestesiol. Olanzapine-induced rhabdomyolysis. Shuster J. Olanzapine and rhabdomyolysis. Quetiapine overdose and severe rhabdomyolysis. Olanzapine overdose is associated with acute muscle toxicity.
Hum Exp Toxicol. Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone. Am J Psychiatry. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone. Ben-Shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem. Rhabdomyolysis in association with simvastatin and amiodarone. Amiodarone's role in simvastatin-associated rhabdomyolysis.
Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir. J Am Board Fam Med. Med J Aust. Biochem Pharmacol. Amiodarone-induced lymphocyte toxicity and mitochondrial function. J Cardiovasc Pharmacol. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II.
Effect of amiodarone AMD on the antioxidant enzymes, lipid peroxidation and mitochondrial metabolism. Cell Biochem Funct. Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-beta1 gene expression but not prevention of mitochondrial dysfunction.
Disruption of mitochondrial function and cellular ATP levels by amiodarone and N-desethylamiodarone in initiation of amiodarone-induced pulmonary cytotoxicity. Aboulafia DM, Johnston R. Simvastatin-induced rhabdomyolysis in an HIV-infected patient with coronary artery disease. Rhabdomyolysis due to probable interaction between simvastatin and ritonavir.
Highly active antiretroviral therapy HAART -associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production. Cell Mol Biol Noisy-le-grand ; 49 — The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells. Antivir Ther. Mitochondrial effects of antiretroviral therapies in asymptomatic patients.
Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity. Neth J Med. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. J Acquir Immune Defic Syndr.
Mitochondrial damage associated with long-term antiretroviral treatment: associated alteration or causal disorder? Brinkman K, Kakuda TN. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?
Curr Opin Infect Dis. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir. Garg H, Blumenthal R. HIV gpinduced apoptosis is mediated by caspasedependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir.
Piliero PJ. Interaction between ritonavir and statins. Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone [letter] Jama.
Thompson M, Samuels S. Rhabdomyolysis with simvastatin and nefazodone. Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis. Rhabdomyolysis associated with simvastatin-nefazodone therapy. Gutierrez CA. Sildenafil-simvastatin interaction: possible cause of rhabdomyolysis?
Am Fam Physician. Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarin. Bhatia V. Massive rhabdomyolysis with simvastatin precipitated by amoxicillin. J Postgrad Med. Andreou ER, Ledger S. Potential drug interaction between simvastatin and danazol causing rhabdomyolysis. Can J Clin Pharmacol. Cytoskeletal myotoxicity from simvastatin and colchicine. Possible colchicine rhabdomyolysis in a fluvastatin-treated patient.
Colchicine-induced acute myopathy in a patient with concomitant use of simvastatin. Clin Neuropharmacol. Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones. Veeraputhiran M, Sundermeyer M. Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
Clin Lung Cancer. Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther. Int J Clin Pharmacol Ther. Concomitant use of cytochrome P 3A4 inhibitors and simvastatin. Molden E, Westergren T. Interaction risk with statin switch. Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations.
Dreier JP, Endres M. Statin-associated rhabdomyolysis triggered by grapefruit consumption. Christopher-Stine L. Statin myopathy: an update. Curr Opin Rheumatol. Safety of aggressive lipid management. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.
Beaird SL. HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles. J Am Pharm Assoc Wash ; 40 — Abbott A. Special section on human genetics: With your genes?
Take one of these, three times a day. Schmitz G, Langmann T. Pharmacogenomics of cholesterol-lowering therapy. Vascul Pharmacol. Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy. J Hum Genet. Vermes A, Vermes I. Genetic polymorphisms in cytochrome P enzymes: effect on efficacy and tolerability of HMG-CoA reductase inhibitors.
Statins and myotoxicity: a therapeutic limitation. Expert Opin Drug Saf. Golomb B, Evans M. Gerschenson M, Brinkman K. Mitochondrial dysfunction in AIDS and its treatment. Intraoperative rhabdomyolysis in a patient receiving pravastatin, a 3-hydroxymethylglutaryl coenzyme A HMG CoA reductase inhibitor. Anesthesia and Analgesia. Gotto AM. Statin myopathy: incidence, risk factors, and pathophysiology. Curr Atheroscler Rep. Sinzinger H, Oguogho A. Variable influence of statins on isoprostanes in hyperlipidemia.
Adv Exp Med Biol. Myocardial preservation by therapy with coenzyme Q10 during heart surgery. Clin Investig. Protection by coenzyme Q10 of canine myocardial reperfusion injury after preservation. J Thorac Cardiovasc Surg. Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting. Ann Thorac Surg. Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion.
J Surg Res. Satoh K, Ichihara K. Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease. For pre-exposure prevention of COVID in adults and pediatric individuals 12 years of age and older weighing at least 40 kg. The FDA approved one drug and many more are being tested in clinical trials. Jan 12 - Despite risk, these meds are important treatments for OUD and pain.
Jan 6 - Serves as milestone for FDA-supported generic drug regulatory research. Guidances, warning letters, drug compounding, international information, registration and listing.
0コメント